From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome–current insights and future directions
B Basil, BK Myke-Mbata, OE Eze… - Clinical Diabetes and …, 2024 - Springer
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing
health concern and the risk of its development is connected with the increasing prevalence …
health concern and the risk of its development is connected with the increasing prevalence …
Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases
C Xu, C Jiang, Z Li, H Gao, J Xian, W Guo, D He… - MedComm, 2024 - Wiley Online Library
Exosomes are nanoscale vesicles of cellular origin. One of the main characteristics of
exosomes is their ability to carry a wide range of biomolecules from their parental cells …
exosomes is their ability to carry a wide range of biomolecules from their parental cells …
[HTML][HTML] Metabolic Dysfunction-Associated Steatotic Liver Disease Is Accompanied by Increased Activities of Superoxide Dismutase, Catalase, and Carbonyl …
G Svobodová, M Šadibolová, E Velecká, L Mráziková… - Antioxidants, 2024 - mdpi.com
Metabolic dysfunction-associated steatotic liver disease (MASLD), one of the leading causes
of chronic liver disorders, is characterized by hepatic lipid accumulation. MASLD causes …
of chronic liver disorders, is characterized by hepatic lipid accumulation. MASLD causes …